Lanean...
Differential pharmacology and clinical utility of empagliflozin in type 2 diabetes
With rates of obesity and diabetes rising across the world, effective therapies to treat hyperglycemia and its associated comorbidities continue to be in demand. Empagliflozin is a highly selective sodium glucose transporter-2 inhibitor that improves serum glucose levels by inducing glucosuria. Take...
Gorde:
| Argitaratua izan da: | Clin Pharmacol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847607/ https://ncbi.nlm.nih.gov/pubmed/27186083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S77754 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|